RDRicardo DiazMDSlidesetHIVBelem HIV Clinical Forum 2019Experience with Dolutegravir in First Line in Brazil - Ricardo Diaz, MDView Slideset
CBCharles BoucherMD, PhDSlidesetHIVBelem HIV Clinical Forum 2019Resistance Considerations When Choosing INSTIs - Charles Boucher, MD, PhDView Slideset
SlidesetHIVBelem HIV Clinical Forum 2019Clinical Case - Gustavo Albino Pinto Magalhães, MD, PhDView Slideset
CFCharles FlexnerMDSlidesetHIVBelem HIV Clinical Forum 2019Pharmacology Considerations When Choosing INSTIs - Charles Flexner, MDView Slideset
PCPedro CahnMD, PhDSlidesetHIVBelem HIV Clinical Forum 2019Simplification of Drug Regimens - Pedro Cahn, MD, PhDView Slideset
OSOmar SuedMSc, MD, PhDSlidesetHIVArgentinian HIV Clinical Forum 2019INSTIs Use in TB Coinfected Patients - Omar Sued, MSc, MD, PhDView Slideset
SlidesetHIVArgentinian HIV Clinical Forum 2019INSTIs Toxicity, Myths and Reality - Gustavo Lopardo, MDView Slideset
MBMarta BoffitoMD, PhD, FRCP, MBASlidesetHIVArgentinian HIV Clinical Forum 2019Novel ARV Delivery Systems - Marta Boffito, MD, PhD, FRCPView Slideset
SlidesetHIVArgentinian HIV Clinical Forum 2019ARV Resistance in Argentina - Horacio SalomonView Slideset
MSMauro SchechterMD, PhDSlidesetHIVArgentinian HIV Clinical Forum 2019INSTIs Use for PrEP? - Mauro Schechter, MD, PhDView Slideset
ACAlexandra CompagnucciMDSlidesetHIVArgentinian HIV Clinical Forum 2019INSTIs Use by Women on Reproductive Age - Alexandra Compagnucci, MDView Slideset
MBMarta BoffitoMD, PhD, FRCP, MBASlidesetHIVArgentinian HIV Clinical Forum 2019What Should We Know About INSTIs Pharmacology - Marta Boffito, MD, PhD, FRCPView Slideset
